SCHEMBL8188174

SCHEMBL8188174

O=C1NC(=O)C(=CC=Cc2ccccn2)S1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 2/20 0.50
▸ HPGD P15428 3/20 0.48
▸ PIK3CA P42336 2/20 0.48
▸ PIK3CG P48736 2/20 0.48
▸ PIM1 P11309 1/20 0.47
▸ PIM3 Q86V86 1/20 0.47
▸ PIM2 Q9P1W9 1/20 0.47
▸ CISD1 Q9NZ45 4/20 0.45
▸ GSK3B P49841 3/20 0.45
▸ MAOA P21397 1/20 0.45
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ CSNK2A2 P19784 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ CLK1 P49759 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1247436 0.83 MTOR (0.64) MTORHPGDPIK3CAPIK3CGPIM1
SCHEMBL1247438 0.83 MTOR (0.64) MTORHPGDPIK3CAPIK3CGPIM1
SCHEMBL13846678 0.78 PIM1 (0.67) HPGDPIM1PIM3PIM2GSK3B
SCHEMBL22409611 0.78 PIM1 (0.67) HPGDPIM1PIM3PIM2GSK3B
SCHEMBL22423780 0.78 PIM1 (0.67) HPGDPIM1PIM3PIM2GSK3B
SCHEMBL22409640 0.76 CISD1 (0.49) MTORHPGDPIK3CAPIK3CGPIM1
SCHEMBL22423741 0.76 CISD1 (0.49) MTORHPGDPIK3CAPIK3CGPIM1
SCHEMBL8172756 0.75 PIM1 (0.57) HPGDPIK3CGPIM1PIM3PIM2
SCHEMBL8187128 0.72 PIM1 (0.53) HPGDPIM1PIM3PIM2GSK3B
SCHEMBL4089557 0.71 PTP4A3 (0.60) HPGDPIK3CGPIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018746-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback